SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Apr 1, 2024
Document Date
Dec 31, 2023
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE